215 related articles for article (PubMed ID: 26699502)
1. Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.
Weinstein S; Toker IA; Emmanuel R; Ramishetti S; Hazan-Halevy I; Rosenblum D; Goldsmith M; Abraham A; Benjamini O; Bairey O; Raanani P; Nagler A; Lieberman J; Peer D
Proc Natl Acad Sci U S A; 2016 Jan; 113(1):E16-22. PubMed ID: 26699502
[TBL] [Abstract][Full Text] [Related]
2. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract][Full Text] [Related]
3. Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines.
Tiemann K; Alluin JV; Honegger A; Chomchan P; Gaur S; Yun Y; Forman SJ; Rossi JJ; Chen RW
Leuk Lymphoma; 2011 Nov; 52(11):2148-54. PubMed ID: 21745168
[TBL] [Abstract][Full Text] [Related]
4. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.
Gladden AB; Woolery R; Aggarwal P; Wasik MA; Diehl JA
Oncogene; 2006 Feb; 25(7):998-1007. PubMed ID: 16247460
[TBL] [Abstract][Full Text] [Related]
5. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
6. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes.
Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Sola B; Roué G
Clin Cancer Res; 2014 Jan; 20(2):393-403. PubMed ID: 24178620
[TBL] [Abstract][Full Text] [Related]
7. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice.
Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y
Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754
[TBL] [Abstract][Full Text] [Related]
8. A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma.
Beltran E; Fresquet V; Martinez-Useros J; Richter-Larrea JA; Sagardoy A; Sesma I; Almada LL; Montes-Moreno S; Siebert R; Gesk S; Calasanz MJ; Malumbres R; Rieger M; Prosper F; Lossos IS; Piris MA; Fernandez-Zapico ME; Martinez-Climent JA
Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12461-6. PubMed ID: 21746927
[TBL] [Abstract][Full Text] [Related]
9. Concurrent inhibition of PI3K and mTORC1/mTORC2 overcomes resistance to rapamycin induced apoptosis by down-regulation of Mcl-1 in mantle cell lymphoma.
Müller A; Zang C; Chumduri C; Dörken B; Daniel PT; Scholz CW
Int J Cancer; 2013 Oct; 133(8):1813-24. PubMed ID: 23580240
[TBL] [Abstract][Full Text] [Related]
10. Dual targeting of the cyclin/Rb/E2F and mitochondrial pathways in mantle cell lymphoma with the translation inhibitor silvestrol.
Alinari L; Prince CJ; Edwards RB; Towns WH; Mani R; Lehman A; Zhang X; Jarjoura D; Pan L; Kinghorn AD; Grever MR; Baiocchi RA; Lucas DM
Clin Cancer Res; 2012 Sep; 18(17):4600-11. PubMed ID: 22791882
[TBL] [Abstract][Full Text] [Related]
11. Grand challenges in modulating the immune response with RNAi nanomedicines.
Goldsmith M; Mizrahy S; Peer D
Nanomedicine (Lond); 2011 Dec; 6(10):1771-85. PubMed ID: 22122585
[TBL] [Abstract][Full Text] [Related]
12. A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40.
Chen J; Zurawski G; Zurawski S; Wang Z; Akagawa K; Oh S; Hideki U; Fay J; Banchereau J; Song W; Palucka AK
J Hematol Oncol; 2015 Apr; 8():35. PubMed ID: 25888530
[TBL] [Abstract][Full Text] [Related]
13. Safety profile of RNAi nanomedicines.
Barros SA; Gollob JA
Adv Drug Deliv Rev; 2012 Dec; 64(15):1730-7. PubMed ID: 22732527
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
Wang M; Sun L; Qian J; Han X; Zhang L; Lin P; Cai Z; Yi Q
Leukemia; 2009 Jul; 23(7):1320-8. PubMed ID: 19225534
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
16. Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.
Medeiros LJ; Hai S; Thomazy VA; Estalilla OC; Romaguera J; Luthra R
Mod Pathol; 2002 May; 15(5):556-64. PubMed ID: 12011261
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of cyclin D1 by small interfering RNA inhibits cell growth and induces apoptosis of laryngeal squamous cell carcinoma.
Xiao Y; Wang J; Lu J; Liu Y; Wang Y; Gao Y; Jin D
Am J Otolaryngol; 2011; 32(6):541-6. PubMed ID: 21315488
[TBL] [Abstract][Full Text] [Related]
18. Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.
Suzuki R; Takemura K; Tsutsumi M; Nakamura S; Hamajima N; Seto M
Am J Pathol; 2001 Aug; 159(2):425-9. PubMed ID: 11485900
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
Xargay-Torrent S; López-Guerra M; Montraveta A; Saborit-Villarroya I; Rosich L; Navarro A; Pérez-Galán P; Roué G; Campo E; Colomer D
Clin Cancer Res; 2013 Feb; 19(3):586-97. PubMed ID: 23231952
[TBL] [Abstract][Full Text] [Related]
20. Functionally associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference.
Ortega-Paino E; Fransson J; Ek S; Borrebaeck CA
Blood; 2008 Feb; 111(3):1617-24. PubMed ID: 18024791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
